HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic polymorphism of KIR2DL4 (CD158d), a putative NK cell receptor for HLA-G, does not influence susceptibility to asthma.

Abstract
Human leukocyte antigen (HLA)-G is upregulated on the bronchial epithelium of asthma patients and genetic polymorphism affecting expression of HLA-G has been reported to influence susceptibility to asthma. As the NK cell receptor KIR2DL4 has been reported to induce interferon gamma (IFNγ) secretion when ligated with HLA-G, we postulated that the 9A/10A genetic polymorphism of KIR2DL4 which influences receptor structure may influence susceptibility to asthma. KIR2DL4 genotypes were determined in two cohorts of children (n = 219 and n = 1356) in whom total serum IgE, allergen-specific IgE, atopy, bronchial reactivity and asthma symptoms had been studied between birth and 14 years. No reproducible associations with KIR2DL4 genotype were identified, leading us to conclude that the KIR2DL4 9A/10A polymorphism has no influence on susceptibility to asthma.
AuthorsM E L Le Page, J P Goodridge, G Zhang, P G Holt, P Sly, C S Witt
JournalTissue antigens (Tissue Antigens) Vol. 82 Issue 4 Pg. 276-9 (Oct 2013) ISSN: 1399-0039 [Electronic] England
PMID24033084 (Publication Type: Journal Article)
Copyright© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • HLA-G Antigens
  • KIR2DL4 protein, human
  • Receptors, KIR2DL4
  • Immunoglobulin E
  • Interferon-gamma
Topics
  • Adolescent
  • Asthma (blood, genetics, immunology, pathology)
  • Bronchial Hyperreactivity (blood, genetics, immunology, pathology)
  • Child
  • Child, Preschool
  • Disease Susceptibility
  • Female
  • HLA-G Antigens (genetics, immunology)
  • Humans
  • Immunoglobulin E (blood)
  • Infant
  • Interferon-gamma (metabolism)
  • Killer Cells, Natural (immunology, pathology)
  • Longitudinal Studies
  • Male
  • Polymorphism, Genetic
  • Receptors, KIR2DL4 (genetics, immunology)
  • Respiratory Mucosa (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: